Print this page    •   Back to Web version of article

The Body Covers: The 12th International AIDS Conference

Poster Session 22404: Pharmacokinetic Interaction Between Nevirapine and Indinavir and Correlation with Antiviral Activity

Coverage provided by Michael Giordano, M.D.

June 30, 1998

Nevirapine and indinavir are metabolized by the same enzyme 'pathway' in the liver -- called the "P450" enzyme -- and therefore have the potential of affecting each other's pharmacokinetics, or the amount, and thus the effect, of each drug in the body.

In this important study presented by The Body's own Robert Murphy, 24 patients who were either naïve or on stable nucleoside RTI treatment began taking the protease inhibitor indinavir (IDV), dosed at 800 mg every 8 hours. After 7 days, patients added the non-nucleoside RTI nevirapine (NVP), dosed at 200 mg once a day, for 14 days (i.e., until Day 21). After Day 21 the dose was raised to 200 mg twice-a-day. Therapy then continued for 58 weeks, with intensive pharmacokinetic (PK) tests performed at days 7 (baseline) and 36.

Dr. Murphy found that at Day 36, there was decrease in the amount of indinavir in the bloodstream as compared with baseline measurements; the decreases were most pronounced in patients who had a particularly high IDV level at day 7. Nonetheless, viral load decreases were still significant, and indinavir levels stayed above the minimum level required for effectiveness.




This article was provided by TheBodyPRO.com. Copyright Body Health Resources Corporation. All rights reserved.

You can find this article online by typing the following address into your Web browser:
http://www.thebody.com/content/art14671.html

Please Note: Knowledge about HIV changes rapidly. Note the date of this article's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this article.

General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your healthcare provider.